Patents by Inventor Fred P. Sherman

Fred P. Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating chronic progressive vascular diseases
    Patent number: 5643892
    Abstract: A method of treating a mammalian patient suffering from a chronic progressive vascular disease (CPVD) characterized by scarring and/or fibrosis to halt the progress of the disease and cause resolution of already-formed scarring or fibrotic lesions. The method consists of the administration to the patient of a pharmaceutical composition containing an effective amount of pentosan polysulfate (PPS) or a pharmaceutically acceptable salt thereof. The oral route of administration is preferred, with total daily dosage of PPS or PPS salt ranging from about 50 to 1200 mg per day.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 1, 1997
    Assignees: Baker Norton Pharmaceuticals, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Gary E. Striker, Liliane J. Striker, Fred P. Sherman
  • Method of treatment for multiple sclerosis
    Patent number: 4994466
    Abstract: A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.
    Type: Grant
    Filed: June 14, 1990
    Date of Patent: February 19, 1991
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventors: Fred P. Sherman, Elliot Hahn
  • Method of treatment for interestitial cystitis
    Patent number: 4877791
    Abstract: A method of treating patients suffering from interstitial cystitis comprises daily administration to such patients of from about 1 to about 50 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
    Type: Grant
    Filed: November 1, 1988
    Date of Patent: October 31, 1989
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventor: Fred P. Sherman
  • Method of treatment for arthritic and inflammatory diseases
    Patent number: 4863928
    Abstract: A method of treating a human or animal patient suffering from an arthritic disease or associated inflammatory disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parental administration may be utilized where suitable.
    Type: Grant
    Filed: January 4, 1989
    Date of Patent: September 5, 1989
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventors: David C. Atkinson, Jack Fishman, Fred P. Sherman
  • Method of treatment for autoimmune diseases
    Patent number: 4857533
    Abstract: A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene or naltrexone may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
    Type: Grant
    Filed: December 15, 1988
    Date of Patent: August 15, 1989
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventors: Fred P. Sherman, David C. Atkinson